The global opioids market was valued at US$ 33,924.2 Mn in 2014. North America was the leading market for opioid, accounting for approximately 65% revenue share in 2014, followed by Europe with around 20% share in 2014.
New York, NY -- (SBWIRE) -- 03/03/2016 -- An opioid is a type of narcotic pain medication that is used to treat moderate to severe pain. It is used as an anesthesia, cough suppressant, diarrhea suppressant and to reduce surgical pain, injury or trauma, cancer pain and pain arising from disease. Opioids are largely used in cancer pain management and end-stage diseases in which palliative care is required. However, these can be addictive due to their analgesic nature.
The global opioids market was valued at US$ 33,924.2 Mn in 2014. North America was the leading market for opioid, accounting for approximately 65% revenue share in 2014, followed by Europe with around 20% share in 2014. Factors such as increasing palliative care facilities, reformed regulations for prescription of opioids, and extensive focus of generic manufacturers towards Abuse-Deterrent Formulation (ADF) are expected to drive the growth of the opioids market in North America and Europe. Asia Pacific market is expected to register highest CAGR of 3.5% during the forecast period (2015–2021), followed by the North America. Increased focus on palliative care and rising healthcare expenditure are leading factors which promote the growth of opioids in Asia Pacific.
Interested in report: Please follow the below the links to meet your requirements; Request for the Report Sample: http://www.persistencemarketresearch.com/samples/3066
The global opioids market has been estimated to be valued at US$ 34,888.0 Mn in 2015 and is anticipate to garner US$ 42,158.8 Mn revenue by 2021, registering a CAGR of 3.2% during the forecast period.
By product, the morphine and codeine segments collectively accounted for around 62% of the overall market in 2014. Uncontrolled prescription, development of opioid tolerance towards morphine and codeine would raise the demand through 2021.
View TOC (table of content), Figures and Tables of the Report: http://www.persistencemarketresearch.com/toc/3066
By application, analgesia segment was valued at US$ 22,776.3 Mn in 2014 and is anticipated to reach US$ 28,436.8 Mn by 2021 at a CAGR of 3.3% over the forecast period.
Key players in the global opioids market include Pfizer Inc., Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Actavis Plc., Sanofi, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals Inc. and Egalet.
For more Info: http://www.persistencemarketresearch.com/contact-us.asp
About Persistence Market Research
Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.